CK
Christopher P Kiritsy
Director

Christopher P Kiritsy insider trades: Palvella Therapeutics (PVLA) stock buys and sales

Director, Palvella Therapeutics Last trade Sep 2, 2026 25 Form 4 filings
$49K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2005
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 2, 2026PVLA↓ Sell$49K
May 25, 2023PIRS↑ Buy$9K
Sep 14, 2018PIRS↑ Buy$26K
May 20, 2005KOSP↓ Sell$275K
May 16, 2005KOSP↓ Sell$934K
May 13, 2005KOSP↓ Sell$133K
May 10, 2005KOSP↓ Sell$810K
May 9, 2005KOSP↓ Sell$3.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PVLA insiders

Open-market trades in the last 12 months

About Christopher P Kiritsy's insider trades

Christopher P Kiritsy is a director at Palvella Therapeutics (PVLA). Since May 9, 2005, Christopher has reported 2 open-market purchases worth $34K and 6 sales worth $5.8M on SEC Form 4. In the last 12 months: 1 sale ($49K).

Their filings also include grants and awards (16 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PVLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.